XERS
NASDAQ · Pharmaceuticals
Xeris Biopharma Holdings Inc
$8.20
+0.04 (+0.49%)
Open$8.10
Previous Close$8.16
Day High$8.25
Day Low$7.93
52W High$10.08
52W Low$5.25
Volume—
Avg Volume1.87M
Market Cap1.36B
P/E Ratio—
EPS$-0.11
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+468.9% upside
Current
$8.20
$8.20
Target
$46.65
$46.65
$35.62
$46.65 avg
$60.75
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 308.03M | 222.65M | 186.74M |
| Net Income | 583.4K | 379.5K | 58.69M |
| Profit Margin | 0.2% | 0.2% | 31.4% |
| EBITDA | 37.72M | 25.90M | 67.69M |
| Free Cash Flow | — | — | 40.84M |
| Rev Growth | +38.4% | +38.4% | +1.9% |
| Debt/Equity | 16.10 | 16.10 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |